Fidelity Investments’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History
Bought
Maintained
Sold
Fidelity Investments's ASTX Position: Q4 2013 in Review
Fidelity Investments sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 60,000 shares — an estimated $509K sold.
Fidelity Investments first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $14.2M in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.
- Fidelity Investments reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
- Fidelity Investments sold 60,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $509K.
- Fidelity Investments first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
- Fidelity Investments's ASTEX PHARMACEUTICALS, INC COM position peaked at $14.2M in Q2 2013.
- 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.
Based on Fidelity Investments's 13F filing for Q4 2013, filed 13 Feb 2014.